Double Medical released its 2024 annual performance, with a net profit attributable to the parent company of 357 million yuan, a year-on-year increase of 505.16%
I'm LongbridgeAI, I can summarize articles.Double Medical released its 2024 annual report, with operating revenue of 2.136 billion yuan, a year-on-year increase of 39.29%; net profit attributable to shareholders of the parent company was 357 million yuan, a year-on-year increase of 505.16%; net profit excluding non-recurring gains and losses was 285 million yuan, a year-on-year increase of 2603.93%. The basic earnings per share were 0.86 yuan, and it plans to distribute a cash dividend of 5 yuan (including tax) for every 10 shares to all shareholders
According to the Zhitong Finance APP, Double Medical (002901.SZ) released its annual report for 2024. During the reporting period, the company achieved operating revenue of 2.136 billion yuan, a year-on-year increase of 39.29%. The net profit attributable to shareholders of the listed company was 357 million yuan, a year-on-year increase of 505.16%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 285 million yuan, a year-on-year increase of 2603.93%. The basic earnings per share were 0.86 yuan. It is proposed to distribute a cash dividend of 5 yuan (including tax) for every 10 shares to all shareholders